Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 10, 2003, Pages 649-656

  Fung, H C ^a   Cohen, S ^a   Rodriguez, R ^a   Smith, D ^a   Krishnan, A ^a   Somlo, G ^a   Sahebi, F ^b   Senitzer, D ^a   O'Donnell, M R ^a   Stein, A ^a   Snyder, D S ^a   Spielberger, R ^b   Bhatia, R ^a   Falk, P ^b   Molina, A ^a   Nademanee, A ^a   Parker, P ^a   Kogut, N ^b   Popplewell, L ^a   Vora, N ^a   Margolin, K ^a   Forman, S J ^a   more..

^a City of Hope   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; Reduced intensity

Indexed keywords

ACICLOVIR; AMPHOTERICIN; BUSULFAN; CARBOPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; MELPHALAN; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; VALGANCICLOVIR;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER RECURRENCE; CAUSE OF DEATH; CHIMERA; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE COURSE; DOSE RESPONSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA REMISSION; MALE; MALIGNANT NEOPLASTIC DISEASE; MYELODYSPLASIA; PANCYTOPENIA; PROGNOSIS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 12144289199     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00241-6     Document Type: Article

References (20)

1. Kolb H.J. Schattenberg A. Goldman J.M. et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 86 1995 2041-2050
2. Collins R.H. Jr Shpilberg O. Drobyski W.R. et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 15 1997 433-444
3. Radich J.P. Gooley T. Sanders J.E. Anasetti C. Chauncey T. Appelbaum F.R. Second allogeneic transplantation after failure of first autologous transplantation Biol Blood Marrow Transplant 6 2000 272-279
4. Krishnan A. Bhatia S. Slovak M.L. et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors Blood 95 2000 1588-1593
5. Slavin S. Nagler A. Naparstek E. et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756-763
6. Giralt S. Estey E. Albitar M. et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 89 1997 4531-4536
7. McSweeney P.A. Niederwieser D. Shizuru J.A. et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood 97 2001 3390-3400
8. Schaffer M. Olerup O. HLA-AB typing by polymerase-chain reaction with sequence-specific primers: more accurate, less errors, and increased resolution compared to serological typing Tissue Antigens 58 2001 299-307
9. Ugozzoli L. Yam P. Petz L.D. et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation Blood 77 1991 1607-1615
10. Przepiorka D. Weisdorf D. Martin P. et al. 1994 Consensus Conference on Acute GVHD Grading Bone Marrow Transplant 15 1995 825-828
11. Shulman H.M. Sullivan K.M. Weiden P.L. et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 69 1980 204-217
12. Ringden O. Labopin M. Gorin N.C. et al. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 25 2000 1053-1058
13. de Lima M. van Besien K.W. Giralt S.A. et al. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma Bone Marrow Transplant 19 1997 121-127
14. Tsai T. Goodman S. Saez R. et al. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation Bone Marrow Transplant 20 1997 859-863
15. Mehta J. Tricot G. Jagannath S. et al. Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft? Bone Marrow Transplant 21 1998 887-892
16. Branson K. Chopra R. Kottaridis P.D. et al. Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies J Clin Oncol 20 2002 4022-4031
17. Martino R. Caballero M.D. de la Serna J. et al. Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant Bone Marrow Transplant 30 2002 63-68
18. Devine S.M. Sanborn R. Jessop E. et al. Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant Bone Marrow Transplant 28 2001 557-562
19. Feinstein L.C. Sandmaier B.M. Maloney D.G. et al. Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant Biol Blood Marrow Transplant 9 2003 266-272
20. Bensinger W.I. Martin P.J. Storer B. et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers N Engl J Med 344 2001 175-181